Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPRX
2351
DELISTED
Repros Therapeutics Inc.
RPRX
| $897K | ﹤0.01% |
741,070
+364,006
| +97% | +$1.17M |
|
2352
Grupo Aeroportuario del Pacifico
PAC
$12.5B
| $893K | ﹤0.01% |
10,113
-16,764
| -62% | -$1.53M |
|
2353
iShares Russell 3000 ETF
IWV
$20.2B
| $892K | ﹤0.01% |
7,417
-6,792
| -48% | -$826K |
|
2354
Royal Gold
RGLD
$22.7B
| $891K | ﹤0.01% |
24,442
-390,963
| -94% | -$16.3M |
|
|
NXRT
2355
NexPoint Residential Trust
NXRT
$624M
| $890K | ﹤0.01% |
67,973
+6,689
| +11% | +$87.7K |
|
2356
UNIFI
UFI
$139M
| $890K | ﹤0.01% |
31,603
-877
| -3% | -$25.9K |
|
2357
NMI Holdings
NMIH
$3.41B
| $889K | ﹤0.01% |
131,362
-247,481
| -65% | -$1.82M |
|
2358
MarineMax
HZO
$1.15B
| $886K | ﹤0.01% |
48,080
-46,543
| -49% | -$774K |
|
2359
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.3B
| $885K | ﹤0.01% |
+32,410
| New | +$902K |
|
2360
RadNet
RDNT
$6.05B
| $883K | ﹤0.01% |
+142,885
| New | +$884K |
|
2361
Tredegar Corp
TG
$276M
| $883K | ﹤0.01% |
64,818
+32,427
| +100% | +$477K |
|
|
SSRG
2362
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $883K | ﹤0.01% |
95,969
+56,065
| +140% | +$499K |
|
2363
Hercules Capital
HTGC
$3.29B
| $875K | ﹤0.01% |
71,749
-211,087
| -75% | -$2.38M |
|
2364
Nordson
NDSN
$18.6B
| $870K | ﹤0.01% |
13,555
+100
| +0.7% | +$6.87K |
|
2365
CALL
ImmunityBio
IBRX
$8.68B
| $867K | ﹤0.01% |
+50,000
| New | +$742K |
|
|
BT
2366
DELISTED
BT Group plc (ADR)
BT
| $866K | ﹤0.01% |
25,011
+16,469
| +193% | +$578K |
|
|
MWW
2367
DELISTED
Monster Worldwide Inc
MWW
| $866K | ﹤0.01% |
151,073
-562,733
| -79% | -$3.63M |
|
|
CPLA
2368
DELISTED
Capella Education Company
CPLA
| $864K | ﹤0.01% |
18,701
-22,157
| -54% | -$1.07M |
|
|
GNCA
2369
DELISTED
Genocea Biosciences, Inc.
GNCA
| $860K | ﹤0.01% |
20,388
-64,216
| -76% | -$3.06M |
|
2370
Greenlight Captial
GLRE
$505M
| $858K | ﹤0.01% |
45,878
+36,669
| +398% | +$781K |
|
2371
Henry Schein
HSIC
$9.99B
| $855K | ﹤0.01% |
13,790
+8,690
| +170% | +$517K |
|
|
ONCE
2372
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $854K | ﹤0.01% |
+18,856
| New | +$988K |
|
2373
Global X MSCI China Consumer Discretionary ETF
CHIQ
$117M
| $851K | ﹤0.01% |
70,000
-5,000
| -7% | -$65.6K |
|
2374
Oshkosh
OSK
$9.58B
| $850K | ﹤0.01% |
+21,770
| New | +$886K |
|
2375
Perdoceo Education
PRDO
$2.09B
| $849K | ﹤0.01% |
233,994
-115,275
| -33% | -$445K |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.